Correlation between Thiopurine S-Methyltransferase Genotype and Adverse Events in Inflammatory Bowel Disease Patients
AbstractBackground and Objectives: In patients with inflammatory bowel diseases (IBD), the use of azathioprine results in adverse events at a rate of 5% to 20%. The aim of the study was to assess a possible correlation between genetic variability of the enzyme thiopurine S-methyltransferase (TPMT) and the development of toxicity to azathioprine. Materials and Methods: A retrospective, single center, blind, case-control study was conducted on 200 IBD patients, of whom 60 cases suspended azathioprine due to toxicity (leukopenia, pancreatitis, hepatitis, and nausea or vomiting), and 140 controls continued treatment with the drug without adverse events. Results: In the entire cohort, only 8 cases of heterozygous mutations of TPMT were observed, corresponding to 4% mutated haplotype rate, much lower than that reported in literature (close to 10%). No homozygous mutation was found. Regarding the TPMT allelic variants, we did not find any statistically significant difference between patients who tolerated azathioprine and those who suffered from adverse events. (OR = 0.77, 95% CI = 0.08–7.72; p = 0.82). Conclusions: According to our study, in IBD patients, the search for TPMT gene mutations before starting treatment with azathioprine is not helpful in predicting the occurrence of adverse events. Importantly, patients with allelic variants should not be denied the therapeutic option of azathioprine, as they may tolerate this drug. View Full-Text
Share & Cite This Article
Ribaldone, D.G.; Adriani, A.; Caviglia, G.P.; De Nicolò, A.; Agnesod, D.; Simiele, M.; Riganò, D.; Pellicano, R.; Canaparo, R.; Di Perri, G.; D’Avolio, A.; Luzza, F.; Abenavoli, L.; Saracco, G.M.; Astegiano, M. Correlation between Thiopurine S-Methyltransferase Genotype and Adverse Events in Inflammatory Bowel Disease Patients. Medicina 2019, 55, 441.
Ribaldone DG, Adriani A, Caviglia GP, De Nicolò A, Agnesod D, Simiele M, Riganò D, Pellicano R, Canaparo R, Di Perri G, D’Avolio A, Luzza F, Abenavoli L, Saracco GM, Astegiano M. Correlation between Thiopurine S-Methyltransferase Genotype and Adverse Events in Inflammatory Bowel Disease Patients. Medicina. 2019; 55(8):441.Chicago/Turabian Style
Ribaldone, Davide G.; Adriani, Alessandro; Caviglia, Gian P.; De Nicolò, Amedeo; Agnesod, Danilo; Simiele, Marco; Riganò, Danila; Pellicano, Rinaldo; Canaparo, Roberto; Di Perri, Giovanni; D’Avolio, Antonio; Luzza, Francesco; Abenavoli, Ludovico; Saracco, Giorgio M.; Astegiano, Marco. 2019. "Correlation between Thiopurine S-Methyltransferase Genotype and Adverse Events in Inflammatory Bowel Disease Patients." Medicina 55, no. 8: 441.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.